Download Limitations of Antimicrobial Susceptibility Testing

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Limitations of Antimicrobial Susceptibility Testing
It is important to understand the limitations of antimicrobial susceptibility testing. It should be recognized that resistance
patterns will change and guidelines will be subject to periodic revision. The interpretation of an antimicrobial susceptibility test
result on a laboratory report must never be taken in isolation. It is important that all factors are taken into account and that it
should be remembered that there is no substitute for sound clinical judgment.
There are cases where susceptibility testing is not indicated. This may include, organisms with predictable susceptibility
patterns, the mode of delivery of the antibiotic to the target site, or in some cases the fact that there are no interpretative
guidelines for the susceptibility of an individual organism and therefore appropriate clinical judgment will be more beneficial
than an in vitro susceptibility test.
The laboratory testing of organisms with predictable susceptibility testing is not recommended by international guidelines. In
these organisms the overwhelming majority (and in some cases all) isolates are susceptible to the recommended antibiotics.
Susceptibility testing of these isolates is therefore not indicated. All that is achieved is that there is a time delay in reporting of
the results, and therefore in the possibility of proper therapy being initiated. Organisms in this category include beta-hemolytic
streptococci and Pasteurella species.
The laboratory routinely tests for the susceptibility of organisms up to a concentration of around 256 µg/ml. However, because
concentrations of antibiotics achieved after topical application are much higher than those which can be safely achieved in
systemic therapy, standardized susceptibility tests are not appropriate to predict its effectiveness.
CLSI guidelines state that both disc diffusion and MIC dilution methods have been standardized for specific organisms.
However for some fastidious organisms, studies are not yet adequate to develop reproducible definitive standards. It is
suggested that susceptibility testing not be carried out due to marked differences in atmosphere, growth rate and strain to
strain variation among isolates.
At IDEXX Laboratories, we are dedicated to providing you with the very best in Veterinary laboratory diagnostics.
Please contact the laboratory on 01937 544000 if you require any further information or assistance.
References
1. Performance standards for antimicrobial disc and dilution susceptibility tests for bacteria isolated from animals. Approved
Standard. CLSI. M31-A. June 1999
2. Performance standards for antimicrobial disc susceptibility tests. Approved Standard. CLSI. M2-A8. January 2003.
3. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard. CLSI. M7-A6.
January 2003.